accessory atrioventricular pathways 的全基因组关联研究
本研究对2310例 accessory atrioventricular pathways(AP)患者和1 206 977例对照进行全基因组关联研究,发现CCDC141和SCN10A基因的三个错义变异与AP相关,且这些变异与PSVT、AF及心脏传导参数相关。
要点
- CCDC141和SCN10A基因变异与AP风险相关。
- AP风险等位基因与PSVT风险增加相关。
- SCN10A变异与AF相关,所有变异与心率增快和PR间期缩短相关。
核心结论
- 序列变异与AP相关,且与PSVT风险相关,可能提示房室折返性心动过速。
- AP风险等位基因对AF和传导障碍具有等位基因特异性关联。
研究设计与样本
- 全基因组关联研究(GWAS),纳入2310例AP患者和1 206 977例对照,来自冰岛、丹麦、美国和英国。
- AP定义基于ICD编码和/或电生理检查确认,其中909例经电生理检查确认。
主要发现
- CCDC141 p.Arg935Trp与AP相关(aOR 1.37,95%CI 1.24-1.52)。
- CCDC141 p.Ala141Val与AP相关(aOR 1.55,95%CI 1.34-1.80)。
- SCN10A p.Ala1073Val与AP相关(OR 1.22,95%CI 1.15-1.30)。
- 三个变异均与PSVT相关,SCN10A变异与AF相关。
- 所有AP风险等位基因与心率增快和PR间期缩短相关。
临床怎么用
- AP患者遗传背景可能影响心律失常风险,需关注心率及传导参数。
- CCDC141可能成为AP相关心律失常的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Understanding of the genetics of accessory atrioventricular pathways (APs) and affiliated arrhythmias is limited. OBJECTIVE: To investigate the genetics of APs and affiliated arrhythmias. DESIGN, SETTING, AND PARTICIPANTS: This was a genome-wide association study (GWAS) of APs, defined by International Classification of Diseases (ICD) codes and/or confirmed by electrophysiology (EP) study. Genome-wide significant AP variants were tested for association with AP-affiliated arrhythmias: paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF), ventricular tachycardia, and cardiac arrest. AP variants were also tested in data on other heart diseases and measures of cardiac physiology. Individuals with APs and control individuals from Iceland (deCODE Genetics), Denmark (Copenhagen Hospital Biobank, Danish Blood Donor Study, and SupraGen/the Danish General Suburban Population Study [GESUS]), the US (Intermountain Healthcare), and the United Kingdom (UK Biobank) were included. Time of phenotype data collection ranged from January 1983 to December 2022. Data were analyzed from August 2022 to January 2024. EXPOSURES: Sequence variants. MAIN OUTCOMES AND MEASURES: Genome-wide significant association of sequence variants with APs. RESULTS: The GWAS included 2310 individuals with APs (median [IQR] age, 43 [28-57] years; 1252 [54.2%] male and 1058 [45.8%] female) and 1 206 977 control individuals (median [IQR] year of birth, 1955 [1945-1970]; 632 888 [52.4%] female and 574 089 [47.6%] male). Of the individuals with APs, 909 had been confirmed in EP study. Three common missense variants were associated with APs, in the genes CCDC141 (p.Arg935Trp: adjusted odds ratio [aOR], 1.37; 95% CI, 1.24-1.52, and p.Ala141Val: aOR, 1.55; 95% CI 1.34-1.80) and SCN10A (p.Ala1073Val: OR, 1.22; 95% CI, 1.15-1.30). The 3 variants associated with PSVT and the SCN10A variant associated with AF, supporting an effect on AP-affiliated arrhythmias. All 3 AP risk alleles were associated with higher heart rate and shorter PR interval, and have reported associations with chronotropic response. CONCLUSIONS AND RELEVANCE: Associations were found between sequence variants and APs that were also associated with risk of PSVT, and thus likely atrioventricular reentrant tachycardia, but had allele-specific associations with AF and conduction disorders. Genetic variation in the modulation of heart rate, chronotropic response, and atrial or atrioventricular node conduction velocity may play a role in the risk of AP-affiliated arrhythmias. Further research into CCDC141 could provide insights for antiarrhythmic therapeutic targeting in the presence of an AP.
引用
- Aegisdottir HM, Andreasen L, Thorolfsdottir RB, et al. Genome-Wide Association Study of Accessory Atrioventricular Pathways. JAMA Cardiol. 2024. PMID: 39230897. doi:10.1001/jamacardio.2024.2684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。